Press Releases

Press Releases

Filters
Viatris Announces Positive Top-Line Results from Phase 3 Study of VR-205 in Japanese Adults with Primary Immunoglobulin A Nephropathy
U.S. FDA Accepts Viatris New Drug Application for Fast-Acting Meloxicam for the Treatment of Moderate-to-Severe Acute Pain
Viatris to Present at the Bank of America Securities 2026 Healthcare Conference
Viatris Reports First-Quarter 2026 Financial Results
Viatris Announces Quarterly Dividend
Viatris Announces Chief Financial Officer Transition
Viatris Announces Several Data Presentations on Investigational Low-Dose Estrogen Combined Hormonal Contraceptive Weekly Patch at the 2026 American College of Obstetricians and Gynecologists Annual Clinical & Scientific Meeting
Viatris to Report First Quarter 2026 Financial Results on May 7, 2026
Viatris Announces Multiple Data Presentations at the 2026 American Society of Cataract and Refractive Surgery Annual Meeting
Viatris Advances Innovative Portfolio with Approval of Effexor® in Japan for Adults with Generalized Anxiety Disorder (GAD)
Displaying 1 - 10 of 194